A detailed history of Ubs Group Ag transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 185,438 shares of CDMO stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,438
Previous 177,421 4.52%
Holding current value
$2.29 Million
Previous $1.27 Million 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $53,713 - $99,811
8,017 Added 4.52%
185,438 $2.11 Million
Q2 2024

Aug 13, 2024

SELL
$6.34 - $9.28 $945,896 - $1.38 Million
-149,195 Reduced 45.68%
177,421 $1.27 Million
Q1 2024

May 13, 2024

BUY
$5.86 - $8.79 $384,169 - $576,254
65,558 Added 25.11%
326,616 $2.19 Million
Q4 2023

Feb 09, 2024

BUY
$4.64 - $9.56 $960,498 - $1.98 Million
207,004 Added 382.96%
261,058 $1.7 Million
Q3 2023

Nov 09, 2023

SELL
$9.4 - $14.04 $306,505 - $457,802
-32,607 Reduced 37.63%
54,054 $510,000
Q2 2023

Aug 11, 2023

BUY
$12.96 - $20.93 $145,113 - $234,353
11,197 Added 14.84%
86,661 $1.21 Million
Q1 2023

May 12, 2023

SELL
$13.48 - $18.79 $1.73 Million - $2.41 Million
-128,073 Reduced 62.92%
75,464 $1.42 Million
Q4 2022

Feb 08, 2023

BUY
$12.61 - $18.74 $2.26 Million - $3.35 Million
178,974 Added 728.63%
203,537 $2.8 Million
Q3 2022

Nov 10, 2022

SELL
$15.33 - $20.36 $201,114 - $267,102
-13,119 Reduced 34.82%
24,563 $470,000
Q2 2022

Aug 10, 2022

SELL
$11.63 - $21.55 $1.98 Million - $3.67 Million
-170,262 Reduced 81.88%
37,682 $575,000
Q1 2022

May 16, 2022

BUY
$16.63 - $27.73 $791,005 - $1.32 Million
47,565 Added 29.66%
207,944 $4.24 Million
Q4 2021

Feb 14, 2022

BUY
$20.7 - $34.18 $566,869 - $936,019
27,385 Added 20.59%
160,379 $4.68 Million
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $1.09 Million - $1.63 Million
57,420 Added 75.98%
132,994 $2.87 Million
Q2 2021

Aug 13, 2021

BUY
$18.93 - $25.65 $831,462 - $1.13 Million
43,923 Added 138.77%
75,574 $1.94 Million
Q1 2021

May 12, 2021

BUY
$11.86 - $21.77 $275,080 - $504,933
23,194 Added 274.26%
31,651 $577,000
Q4 2020

Feb 11, 2021

BUY
$7.25 - $11.76 $61,313 - $99,454
8,457 New
8,457 $98,000
Q3 2020

Nov 12, 2020

SELL
$6.53 - $8.6 $116,573 - $153,527
-17,852 Closed
0 $0
Q2 2020

Jul 31, 2020

SELL
$4.11 - $6.78 $65,435 - $107,944
-15,921 Reduced 47.14%
17,852 $117,000
Q1 2020

May 01, 2020

SELL
$3.15 - $7.39 $122,242 - $286,783
-38,807 Reduced 53.47%
33,773 $173,000
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $190,014 - $309,484
37,927 Added 109.45%
72,580 $557,000
Q3 2019

Nov 14, 2019

BUY
$5.07 - $7.08 $81,697 - $114,087
16,114 Added 86.92%
34,653 $184,000
Q2 2019

Aug 14, 2019

BUY
$3.43 - $5.6 $28,016 - $45,740
8,168 Added 78.76%
18,539 $104,000
Q1 2019

May 14, 2019

SELL
$3.56 - $4.82 $97,793 - $132,405
-27,470 Reduced 72.59%
10,371 $44,000
Q4 2018

Feb 14, 2019

BUY
$4.04 - $6.75 $29,908 - $49,970
7,403 Added 24.32%
37,841 $155,000
Q3 2018

Nov 14, 2018

BUY
$4.28 - $7.32 $37,176 - $63,581
8,686 Added 39.93%
30,438 $209,000
Q2 2018

Aug 14, 2018

BUY
$3.1 - $3.93 $58,574 - $74,257
18,895 Added 661.36%
21,752 $86,000
Q1 2018

May 15, 2018

BUY
$2.32 - $4.22 $6,628 - $12,056
2,857 New
2,857 $8,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $768M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.